Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease

Journal of Neurochemistry

Volumn 127, Issue 3, 2013, Pages 415-425

  Ostapchenko, Valeriy G ^a   Beraldo, Flavio H ^a   Guimarães, Andre L S ^a,b   Mishra, Sanju ^a   Guzman, Monica ^a   Fan, Jue ^a   Martins, Vilma R ^c   Prado, Vania F ^a,d   Prado, Marco A M ^a,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

ADAM10; Alzheimer's disease; cellular prion protein; metabotropic glutamate receptor; prion protein processing; transgenic mouse model

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN; METABOTROPIC RECEPTOR 1; PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; ENZYME LOCALIZATION; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION;

ADAM10; ALZHEIMER'S DISEASE; CELLULAR PRION PROTEIN; METABOTROPIC GLUTAMATE RECEPTOR; PRION PROTEIN PROCESSING; TRANSGENIC MOUSE MODEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DOCOSAHEXAENOIC ACIDS; INFLAMMATION; NEUROPROTECTIVE AGENTS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84886100578     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12296     Document Type: Article

References (74)

1. Albasanz J. L., Dalfo E., Ferrer I., and, Martin M., (2005) Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol. Dis. 20, 685-693.
2. Altmeppen H. C., Prox J., Puig B., et al,. (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol. Neurodegener. 6, 36.
3. Ashe K. H., and, Zahs K. R., (2010) Probing the biology of Alzheimer's disease in mice. Neuron 66, 631-645.
4. Balducci C., Beeg M., Stravalaci M., et al,. (2010) Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl Acad. Sci. USA 107, 2295-2300.
5. Barry A. E., Klyubin I., Mc Donald J. M., Mably A. J., Farrell M. A., Scott M., Walsh D. M., and, Rowan M. J,. (2011) Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259-7263.
6. Beland M., and, Roucou X., (2012) The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. J. Neurochem. 120, 853-868.
7. Beland M., Motard J., Barbarin A., and, Roucou X., (2012) PrPC Homodimerization Stimulates the Production of PrPC Cleaved Fragments PrPN1 and PrPC1. J. Neurosci. 32, 13255-13263.
8. Benilova I., and, De S. B., (2010) Prion protein in Alzheimer's pathogenesis: a hot and controversial issue. EMBO Mol. Med. 2, 289-290.
9. Beraldo F. H., Arantes C. P., Santos T. G., et al,. (2011) Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain. FASEB J. 25, 265-279.
10. Blaabjerg M., Fang L., Zimmer J., and, Baskys A., (2003) Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents. Exp. Neurol. 183, 573-580.
11. Bomfim T. R., Forny-Germano L., Sathler L. B., et al,. (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers. J. Clin. Invest. 122, 1339-1353.
12. Caetano F. A., Lopes M. H., Hajj G. N., et al,. (2008) Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J. Neurosci. 28, 6691-6702.
13. Caetano F. A., Beraldo F. H., Hajj G. N., et al,. (2011) Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J. Neurochem. 117, 538-553.
14. Calella A. M., Farinelli M., Nuvolone M., Mirante O., Moos R., Falsig J., Mansuy I. M., and, Aguzzi A., (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314.
15. Chen S. G., Teplow D. B., Parchi P., Teller J. K., Gambetti P., and, Autilio-Gambetti L., (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173-19180.
16. Chen S., Yadav S. P., and, Surewicz W. K., (2010) Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J. Biol. Chem. 285, 26377-26383.
17. Chung E., Ji Y., Sun Y., Kascsak R. J., Kascsak R. B., Mehta P. D., Strittmatter S. M., and, Wisniewski T., (2010) Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci. 11, 130.
18. Cisse M. A., Sunyach C., Lefranc-Jullien S., Postina R., Vincent B., and, Checler F., (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 280, 40624-40631.
19. Cosgrove K. E., Galvan E. J., Barrionuevo G., and, Meriney S. D., (2011) mGluRs modulate strength and timing of excitatory transmission in hippocampal area CA3. Mol. Neurobiol. 44, 93-101.
20. De Felice F. G., (2013) Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123, 531-539.
21. De Felice F. G., Vieira M. N., Bomfim T. R., Decker H., Velasco P. T., Lambert M. P., Viola K. L., Zhao W. Q., Ferreira S. T., and, Klein W. L., (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl Acad. Sci. USA 106, 1971-1976.
22. Decker H., Jurgensen S., Adrover M. F., Brito-Moreira J., Bomfim T. R., Klein W. L., Epstein A. L., De Felice F. G., Jerusalinsky D., and, Ferreira S. T., (2010) N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-beta peptide oligomers. J. Neurochem. 115, 1520-1529.
23. Dron M., Moudjou M., Chapuis J., Salamat M. K., Bernard J., Cronier S., Langevin C., and, Laude H., (2010) Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J. Biol. Chem. 285, 10252-10264.
24. Ferreira S. T., and, Klein W. L., (2011) The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 96, 529-543.
25. Ferretti M. T., Partridge V., Leon W. C., et al,. (2011) Transgenic mice as a model of pre-clinical Alzheimer's disease. Curr. Alzheimer Res. 8, 4-23.
26. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., and, Raposo G., (2004) Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683-9688.
27. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., and, Weissmann C., (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264.
28. Freir D. B., Nicoll A. J., Klyubin I., Panico S., Mc Donald J. M., Risse E., Asante E. A., Farrow M. A., Sessions R. B., Saibil H. R., Clarke A. R., Rowan M. J., Walsh D. M., and, Collinge J,. (2011) Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336.
29. Garcia-Alloza M., Prada C., Lattarulo C., Fine S., Borrelli L. A., Betensky R., Greenberg S. M., Frosch M. P., and, Bacskai B. J., (2009) Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J. Neurochem. 109, 1636-1647.
30. Gimbel D. A., Nygaard H. B., Coffey E. E., Gunther E. C., Lauren J., Gimbel Z. A., and, Strittmatter S. M., (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374.
31. Guillot-Sestier M. V., Sunyach C., Druon C., Scarzello S., and, Checler F., (2009) The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J. Biol. Chem. 284, 35973-35986.
32. Guillot-Sestier M. V., Sunyach C., Ferreira S. T., Marzolo M. P., Bauer C., Thevenet A., and, Checler F., (2012) alpha-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death. J. Biol. Chem. 287, 5021-5032.
33. Gutwein P., Stoeck A., Riedle S., et al,. (2005) Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 11, 2492-2501.
34. Guzman M. S., De Jaeger X., Raulic S., et al,. (2011) Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol. 9, e1001194.
35. Jankowsky J. L., Fadale D. J., Anderson J., et al,. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159-170.
36. Kessels H. W., Nguyen L. N., Nabavi S., and, Malinow R., (2010) The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4.
37. Klein W. L., (2002) Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345-352.
38. Lambert M. P., Barlow A. K., Chromy B. A., et al,. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
39. Lauren J., Gimbel D. A., Nygaard H. B., Gilbert J. W., and, Strittmatter S. M., (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132.
40. Lewis H. D., Beher D., Smith D., et al,. (2004) Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD. Neurobiol. Aging 25, 1175-1185.
41. Li S., Hong S., Shepardson N. E., Walsh D. M., Shankar G. M., and, Selkoe D., (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801.
42. Lichtenthaler S. F., (2011) Alpha-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J. Neurochem. 116, 10-21.
43. Linden R., Martins V. R., Prado M. A., Cammarota M., Izquierdo I., and, Brentani R. R., (2008) Physiology of the prion protein. Physiol. Rev. 88, 673-728.
44. Lindner A. B., and, Demarez A., (2009) Protein aggregation as a paradigm of aging. Biochim. Biophys. Acta 1790, 980-996.
45. Lopes M. H., Hajj G. N., Muras A. G., Mancini G. L., Castro R. M., Ribeiro K. C., Brentani R. R., Linden R., and, Martins V. R., (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25, 11330-11339.
46. Luscher C., and, Huber K. M., (2010) Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65, 445-459.
47. Magdesian M. H., Nery A. A., Martins A. H., Juliano M. A., Juliano L., Ulrich H., and, Ferreira S. T., (2005) Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta. J. Biol. Chem. 280, 31085-31090.
48. Mange A., Beranger F., Peoc'h K., Onodera T., Frobert Y., and, Lehmann S., (2004) Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein. Biol. Cell 96, 125-132.
49. Martins V. R., Linden R., Prado M. A., Walz R., Sakamoto A. C., Izquierdo I., and, Brentani R. R., (2002) Cellular prion protein: on the road for functions. FEBS Lett. 512, 25-28.
50. Martins-Silva C., De Jaeger X., Guzman M. S., Lima R. D., Santos M. S., Kushmerick C., Gomez M. V., Caron M. G., Prado M. A., and, Prado V. F,. (2011) Novel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior. PLoS One 6, e17611.
51. McMahon H. E., Mange A., Nishida N., Creminon C., Casanova D., and, Lehmann S., (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J. Biol. Chem. 276, 2286-2291.
52. Morales R., Estrada L. D., Diaz-Espinoza R., Morales-Scheihing D., Jara M. C., Castilla J., and, Soto C., (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J. Neurosci. 30, 4528-4535.
53. Parameshwaran K., Dhanasekaran M., and, Suppiramaniam V., (2008) Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp. Neurol. 210, 7-13.
54. Pellegrini-Giampietro D. E., (2003) The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol. Sci. 24, 461-470.
55. Prusiner S. B., (1998) Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383.
56. Reiserer R. S., Harrison F. E., Syverud D. C., and, McDonald M. P., (2007) Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav. 6, 54-65.
57. Renner M., Lacor P. N., Velasco P. T., Xu J., Contractor A., Klein W. L., and, Triller A., (2010) Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 66, 739-754.
58. Sagara Y., and, Schubert D., (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18, 6662-6671.
59. Savonenko A., Xu G. M., Melnikova T., Morton J. L., Gonzales V., Wong M. P., Price D. L., Tang F., Markowska A. L., and, Borchelt D. R., (2005) Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis. 18, 602-617.
60. Selkoe D. J,. (2011) Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 3, 1-16.
61. Snyder E. M., Nong Y., Almeida C. G., et al,. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058.
62. Stoeck A., Keller S., Riedle S., Sanderson M. P., Runz S., Le N. F., Gutwein P., Ludwig A., Rubinstein E., and, Altevogt P., (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 393, 609-618.
63. Taylor D. R., Parkin E. T., Cocklin S. L., Ault J. R., Ashcroft A. E., Turner A. J., and, Hooper N. M., (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J. Biol. Chem. 284, 22590-22600.
64. Vincent A. M., and, Maiese K., (2000) The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death. Exp. Neurol. 166, 65-82.
65. Vincent B., Beaudet A., Dauch P., Vincent J. P., and, Checler F., (1996) Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes. J. Neurosci. 16, 5049-5059.
66. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., De S. B., Grassi J., Lopez-Perez E., and, Checler F., (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276, 37743-37746.
67. Walmsley A. R., Watt N. T., Taylor D. R., Perera W. S., and, Hooper N. M., (2009) alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol. Cell. Neurosci. 40, 242-248.
68. Walsh D. M., and, Selkoe D. J., (2007) A beta oligomers-a decade of discovery. J. Neurochem. 101, 1172-1184.
69. Wang H. Y., Lee D. H., D'Andrea M. R., Peterson P. A., Shank R. P., and, Reitz A. B., (2000) beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626-5632.
70. Westergard L., Turnbaugh J. A., and, Harris D. A., (2011) A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J. Biol. Chem. 286, 44234-44242.
71. Xie L., Helmerhorst E., Taddei K., Plewright B., Van B. W., and, Martins R,. (2002) Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22, RC221.
72. Zanata S. M., Lopes M. H., Mercadante A. F., et al,. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316.
73. Zhao W. Q., Lacor P. N., Chen H., Lambert M. P., Quon M. J., Krafft G. A., and, Klein W. L., (2009) Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J. Biol. Chem. 284, 18742-18753.
74. Zhu P., DeCoster M. A., and, Bazan N. G., (2004) Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. J. Neurosci. Res. 77, 525-531.